HR 3689 · 110th Congress 2007–2009, ended

Ovarian Cancer Biomarker Research Act of 2007

Latest action · Nov 8, 2007 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedSep 27, 2007
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.

Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such biomarkers; (3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; and (4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens.

Requires the Director to: (1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS); (2) establish an Ovarian Cancer Biomarker Clinical Trial Committee to assist the Director to design and implement national clinical trials to determine the utility of such biomarkers; and (3) establish a national data center to conduct statistical analyses of trial data.

Cosponsors 97

Members who signed on, in the order they did. Signatures ran from Sep 27, 2007 to Sep 23, 2008; 21 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NYAnthony D. WeinerOriginalSep 27, 2007
D-CABarbara LeeOriginalSep 27, 2007
D-ILBobby L. RushOriginalSep 27, 2007
D-NYCarolyn McCarthyOriginalSep 27, 2007
R-INDan BurtonOriginalSep 27, 2007
R-CADarrell IssaOriginalSep 27, 2007
D-CAEllen O. TauscherOriginalSep 27, 2007
D-MOEmanuel CleaverOriginalSep 27, 2007
R-VAFrank R. WolfOriginalSep 27, 2007
D-TXGene GreenOriginalSep 27, 2007
R-CAGeorge RadanovichOriginalSep 27, 2007
D-WAJim McDermottOriginalSep 27, 2007
R-VAJo Ann DavisOriginalSep 27, 2007
D-CAMichael M. HondaOriginalSep 27, 2007
D-NYMichael R. McNultyOriginalSep 27, 2007

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Sep 27, 2007
Health Subcommittee
Referred Nov 8, 2007

Actions 4

Everything that happened, newest first.

  1. Nov 8, 2007Referred to the Subcommittee on Health.
  2. Sep 28, 2007Sponsor introductory remarks on measure. (CR E2019-2020)
  3. Sep 27, 2007Introduced in House
  4. Sep 27, 2007Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
ExtensionsDebate and remarks E2017, E2019Howard L. Berman D-CA, Ralph M. Hall R-TXSep 28, 2007

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 3

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2569Ovarian Cancer Biomarker Research Act of 2008Related billJan 29, 2008

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer.
Short Titles as Introduced
Ovarian Cancer Biomarker Research Act of 2007

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Sep 27, 2007Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.